PAK4 and intestinal neoplasm: To determine the effect of PF-3758309 (selective for PAK1 and PAK4 [5, 18]) on the immune response to intestinal tumour growth in mice with a functional immune system, APC∆14/+ mice were treated with PF-3758309 from 10 to 20 weeks of age.